Bellone, S., Buza, N., Choi, J., Zammataro, L., Gay, L., Elvin, J., . . . Santin, A. D. (2018). Exceptional response to pembrolizumab in a metastatic, chemotherapy/radiation-resistant ovarian cancer patient harboring a PD-L1-genetic rearrangement. Clin Cancer Res.
Citación estilo ChicagoBellone, Stefania, et al. "Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/radiation-resistant Ovarian Cancer Patient Harboring a PD-L1-genetic Rearrangement." Clin Cancer Res 2018.
Cita MLABellone, Stefania, et al. "Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/radiation-resistant Ovarian Cancer Patient Harboring a PD-L1-genetic Rearrangement." Clin Cancer Res 2018.
Precaución: Estas citas no son 100% exactas.